EIF3M and cancer: Pan-cancer analysis revealed that EIF3M exhibited significantly elevated gene activity scores across 15 tumor types, including BLCA, BRCA, CHOL, COAD, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LIHC, LUAD, PRAD, READ, and UCEC.